Abstract 3845: Antitumor activity of SEL120: An orally available dual inhibitors of Haspin/CDK9, for standalone and combination therapy with AuroraB inhibitors in solid tumors and hematopoietic malignanciesTomasz Rzymski, Nicolas Beuzen, Adrian Zarębski et al.|Cancer Research|2012Cited by 3
Abstract 4499: In vitro and in vivo evaluation of novel Pim kinase inhibitors with potent anticancer activityKrzysztof Brzózka, Nicolas Beuzen, Ewa Trębacz et al.|Cancer Research|2010Cited by 1
63 Efficacy evaluation of novel Pim kinase inhibitors with anticancer activityKrzysztof Brzózka, Nicolas Beuzen, Adrian Zarębski et al.|European Journal of Cancer Supplements|2010Cited by 0
Abstract 696: Development of selective CDK8 inhibitors for colorectal cancer and mantle cell lymphoma treatment.Tomasz Rzymski, Krzysztof Brzózka, Adrian Zarębski et al.|Cancer Research|2013Cited by 0
Abstract B242: Antitumor activity of SEL120: An orally available small-molecule inhibitor of Haspin kinase for standalone and combination therapy with AuroraB inhibitors in colorectal cancer.Tomasz Rzymski, Krzysztof Brzózka, Adrian Zarębski et al.|Molecular Cancer Therapeutics|2011Cited by 0